TY - CHAP M1 - Book, Section TI - Examination of Motor Function: Motor Control and Motor Learning A1 - O’Sullivan, Susan B. A1 - Shaffer, Scott W. A1 - McKibben, Richard J. A2 - Fulk, George D. A2 - Chui, Kevin K. PY - 2024 T2 - O’Sullivan & Schmitz’s Physical Rehabilitation, 8th Edition AB - LEARNING OBJECTIVESIdentify the purposes and components of the examination of motor structure and function: motor control and motor learning.Discuss potential constraining factors that can affect an examination of motor function, including sensory, perceptual, cognitive, and communication deficits.Describe the examination of activities and participation.Describe the examination of the movement system.Describe the examination of impairments of body structure and function of the movement system and the implication of common deficits for function.Describe the measures used in the assessment of motor learning.Discuss the importance of examining and promoting patient involvement in decision-making and assessment of problem-solving skills.Compare and contrast the advantages, disadvantages, and utilization of imaging tests, including radiography, computed tomography (CT) scan, magnetic resonance imaging (MRI), diffusion tensor imaging (DTI), functional magnetic resonance imaging (fMRI), spectrum photon emission computed tomography (SPECT), and positron emission tomography (PET).Compare and contrast the advantages, disadvantages, and utilization of electrophysiologic neuromuscular assessments to include nerve conduction studies (NCS), electromyography (EMG), electroencephalography (EEG), and transmagnetic stimulation (TMS).Discuss factors that influence determination of the physical therapy diagnosis with disorders of motor function.Analyze and interpret patient data, formulate realistic goals and expected outcomes, and identify appropriate interventions when presented with a clinical case study.Compare and contrast the clinical examination findings associated with various central nervous health conditions (see Table 5.14).Compare and contrast the clinical examination findings associated with various neuromuscular diseases (see Table 5.15). SN - PB - F. A. Davis Company CY - New York, NY Y2 - 2024/10/07 UR - fadavispt.mhmedical.com/content.aspx?aid=1207746779 ER -